{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hemochromatosis-type-4","columns":[{"gene":"","key":"population-6d73f3f26ec58773eb80","label":"Hemochromatosis, type 4","mondoId":"MONDO:0011631","onsetQualifier":null,"originColumnKey":"MONDO:0011631/OMIM:606069","originalViews":[{"key":"MONDO:0011631/OMIM:606069","label":"Hemochromatosis, type 4","scopeLabel":"OMIM:606069","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["111c3cfa85167699515e04752406cd997c11458571e85353318a51992cb1b148","120789b79751670f7242d9331d26c546d1b153ab77129d0272ed5d53e4cd68e3","337a54df54ac86a9c7ce4bf3f9053c06ef38c33b5f60a77d92fb1d4945e7f334","5e6ef763871b297d9d39705f2faeaf796db695fb537a50f39158d9656c35e996","5ef45e6bcf243ff8f72d8e6db4de2696d1243a72e9eb17cb76fb5d7eb98dc305","741453d6b8159055e20ae1c1ef553a1186be925aa51fe7343343ad74796e3f8a","7facc06b66f4e1f6778d42e4929cf7f4fa39f562d987844cc81bcd41629435cf","84df71d6eb7ef748f963f3103ab73f3cf24fd6492cc5ebb809cedfb7d54d0bf6","85062b361b542c7cbbe2b3fa6f2c7faa433c45c8b5c4d86d2a738b8b9cd5e9c7","a85cfb243869b87ea59af597fe095dbcb7aa12cebd8549056fd6b3cca871e8e3","cc47674ea80e769473f654a9abb86a6b9e31fb7cc75dd55286cfe77341b60f91","d3fbb7f31d79289a89315ed13c637222d96bed08bb4fbeabf6fc51713fd355a6","d6cee86971c7d5ecf4ce9e52b6201096b7cbcb9444f150ba5625ccb7d57a4ce8","dec6486b22c9a842ea3c7d9c26433926937d63f4abb30c046a877aa79230b6da","e8642cc71e68dd62f9b819b7e787c0699a575aae2f04f5868c39f4afae495fe7","f880d72f556d02d5074828ce23b52dae260f97033591a1a155eb581848e7a324","fc7c37d823720b84b642ac7c239f69e4c26b43339f9e9cd3e6e94aebe8493e66"],"recordQualifiers":{},"scopeLabel":"OMIM:606069","sourceIds":["OMIM:606069"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6d73f3f26ec58773eb80"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001903","HP:0011675","HP:0002829","HP:0001638","HP:0000518","HP:0001394","HP:0000819"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":10,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"omim":6,"published":11}},"features":[{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0011675","label":"Arrhythmia","primary":true},{"hpoId":"HP:0002829","label":"Arthralgia","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0000518","label":"Cataract","primary":true},{"hpoId":"HP:0001394","label":"Cirrhosis","primary":true},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":true},{"hpoId":"HP:0012463","label":"Elevated transferrin saturation","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0001952","label":"Glucose intolerance","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0000953","label":"Hyperpigmentation of the skin","primary":false},{"hpoId":"HP:0040270","label":"Impaired glucose tolerance","primary":false},{"hpoId":"HP:0000802","label":"Impotence","primary":false},{"hpoId":"HP:0003281","label":"Increased circulating ferritin concentration","primary":false},{"hpoId":"HP:0002758","label":"Osteoarthritis","primary":false}],"ledeHtml":"Hemochromatosis type 4 (also called ferroportin disease) is a disease in which too much iron builds up in the body. This is also called iron overload. Accumulation of iron in the organs is toxic and can cause organ damage. While many organs can be affected, iron overload is especially likely to affect the liver, heart, and pancreas. Hemochromatosis type 4A Hemochromatosis type 4B People with Hemochromatosis type 4A might not have any symptoms of the disease. Other individuals may develop liver disease as they get older. Hemochromatosis type 4B can be associated with fatigue, weakness, and joint pain. Other symptoms may include abdominal pain, loss of sex drive, liver disease, diabetes, heart problems, difficulty breathing, and skin discoloration. Symptoms of Hemochromatosis type 4B can begin anytime from childhood to adulthood. Hemochromatosis type 4 is most common in people of southern European ancestry. Hemochromatosis type 4 is caused by genetic changes (genetic changes or pathogenic variants) to the SLC40A1 gene. The disease is inherited in an autosomal dominant manner. A diagnosis of Hemochromatosis type 4 is suspected when a doctor observes signs and symptoms of the disease. A doctor may decide to order laboratory tests including a liver biopsy, MRI, or blood test. The diagnosis can be confirmed with genetic testing.","mondoId":"MONDO:0011631","node":{"canonicalSlug":"hemochromatosis-type-4","comparisons":[{"documentSha256":"a84aa28f475aacbd135cae46ce7e1e1bd8aec6509c1a9a0dca4090b417342a59","key":"legacy-hereditary-hemochromatosis","kind":"legacy","label":"hereditary hemochromatosis","memberIds":["MONDO:0006507","MONDO:0009275","MONDO:0011012","MONDO:0011216","MONDO:0011417","MONDO:0011631","MONDO:0013220","MONDO:0014225","MONDO:0019257"],"mondoId":"MONDO:0006507","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hereditary-hemochromatosis.a84aa28f475aacbd135cae46ce7e1e1bd8aec6509c1a9a0dca4090b417342a59.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hemochromatosis type 4","originalSourceId":"ORPHA:139491","paragraphs":["Hemochromatosis type 4 (also called ferroportin disease) is a disease in which too much iron builds up in the body. This is also called iron overload. Accumulation of iron in the organs is toxic and can cause organ damage. While many organs can be affected, iron overload is especially likely to affect the liver, heart, and pancreas. Hemochromatosis type 4A Hemochromatosis type 4B People with Hemochromatosis type 4A might not have any symptoms of the disease. Other individuals may develop liver disease as they get older. Hemochromatosis type 4B can be associated with fatigue, weakness, and joint pain. Other symptoms may include abdominal pain, loss of sex drive, liver disease, diabetes, heart problems, difficulty breathing, and skin discoloration. Symptoms of Hemochromatosis type 4B can begin anytime from childhood to adulthood. Hemochromatosis type 4 is most common in people of southern European ancestry. Hemochromatosis type 4 is caused by genetic changes (genetic changes or pathogenic variants) to the SLC40A1 gene. The disease is inherited in an autosomal dominant manner. A diagnosis of Hemochromatosis type 4 is suspected when a doctor observes signs and symptoms of the disease. A doctor may decide to order laboratory tests including a liver biopsy, MRI, or blood test. The diagnosis can be confirmed with genetic testing."],"rawAttribution":"MONDO:0011631","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:57Z","upstream":"GARD:0010094","url":"https://rarediseases.info.nih.gov/diseases/10094"},"ownColumnKeys":["population-6d73f3f26ec58773eb80"],"publication":"published","relationships":[{"kind":"parent","label":"hereditary hemochromatosis","mondoId":"MONDO:0006507","slug":"hereditary-hemochromatosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"111c3cfa85167699515e04752406cd997c11458571e85353318a51992cb1b148","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"3/20","hpo_id":"HP:0012463","is_excluded":false,"label":"Elevated transferrin saturation","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"120789b79751670f7242d9331d26c546d1b153ab77129d0272ed5d53e4cd68e3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"1/20","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"337a54df54ac86a9c7ce4bf3f9053c06ef38c33b5f60a77d92fb1d4945e7f334","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0040270","is_excluded":false,"label":"Impaired glucose tolerance","onset_id":null,"reference":"OMIM:606069","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5e6ef763871b297d9d39705f2faeaf796db695fb537a50f39158d9656c35e996","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"5ef45e6bcf243ff8f72d8e6db4de2696d1243a72e9eb17cb76fb5d7eb98dc305","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002829","is_excluded":false,"label":"Arthralgia","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"741453d6b8159055e20ae1c1ef553a1186be925aa51fe7343343ad74796e3f8a","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"2/20","hpo_id":"HP:0000953","is_excluded":false,"label":"Hyperpigmentation of the skin","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7facc06b66f4e1f6778d42e4929cf7f4fa39f562d987844cc81bcd41629435cf","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"OMIM:606069","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"84df71d6eb7ef748f963f3103ab73f3cf24fd6492cc5ebb809cedfb7d54d0bf6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"2/20","hpo_id":"HP:0002758","is_excluded":false,"label":"Osteoarthritis","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"85062b361b542c7cbbe2b3fa6f2c7faa433c45c8b5c4d86d2a738b8b9cd5e9c7","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"OMIM:606069","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"a85cfb243869b87ea59af597fe095dbcb7aa12cebd8549056fd6b3cca871e8e3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"3/11","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cc47674ea80e769473f654a9abb86a6b9e31fb7cc75dd55286cfe77341b60f91","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"TAS","frequency_raw":"6/20","hpo_id":"HP:0003281","is_excluded":false,"label":"Increased circulating ferritin concentration","onset_id":null,"reference":"OMIM:606069","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d3fbb7f31d79289a89315ed13c637222d96bed08bb4fbeabf6fc51713fd355a6","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001952","is_excluded":false,"label":"Glucose intolerance","onset_id":null,"reference":"OMIM:606069","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d6cee86971c7d5ecf4ce9e52b6201096b7cbcb9444f150ba5625ccb7d57a4ce8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"1/20","hpo_id":"HP:0011675","is_excluded":false,"label":"Arrhythmia","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"dec6486b22c9a842ea3c7d9c26433926937d63f4abb30c046a877aa79230b6da","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000802","is_excluded":false,"label":"Impotence","onset_id":null,"reference":"OMIM:606069","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e8642cc71e68dd62f9b819b7e787c0699a575aae2f04f5868c39f4afae495fe7","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"1/11","hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f880d72f556d02d5074828ce23b52dae260f97033591a1a155eb581848e7a324","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"5/20","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fc7c37d823720b84b642ac7c239f69e4c26b43339f9e9cd3e6e94aebe8493e66","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:606069","disease_name":"Hemochromatosis, type 4","evidence":"PCS","frequency_raw":"2/20","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"PMID:11431687","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10094\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011631\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010094</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hemochromatosis type 4 (also called ferroportin disease) is a disease in which too much iron builds up in the body. This is also called iron overload. Accumulation of iron in the organs is toxic and can cause organ damage. While many organs can be affected, iron overload is especially likely to affect the liver, heart, and pancreas. Hemochromatosis type 4A Hemochromatosis type 4B People with Hemochromatosis type 4A might not have any symptoms of the disease. Other individuals may develop liver disease as they get older. Hemochromatosis type 4B can be associated with fatigue, weakness, and joint pain. Other symptoms may include abdominal pain, loss of sex drive, liver disease, diabetes, heart problems, difficulty breathing, and skin discoloration. Symptoms of Hemochromatosis type 4B can begin anytime from childhood to adulthood. Hemochromatosis type 4 is most common in people of southern European ancestry. Hemochromatosis type 4 is caused by genetic changes (genetic changes or pathogenic variants) to the SLC40A1 gene. The disease is inherited in an autosomal dominant manner. A diagnosis of Hemochromatosis type 4 is suspected when a doctor observes signs and symptoms of the disease. A doctor may decide to order laboratory tests including a liver biopsy, MRI, or blood test. The diagnosis can be confirmed with genetic testing.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10094\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"hemochromatosis-type-4","sourceDocuments":[{"name":"GARD: Hemochromatosis type 4","reviewed":null,"source_release":"2026-10-25T03:40:57Z","url":"https://rarediseases.info.nih.gov/diseases/10094"},{"name":"MONDO: hemochromatosis type 4","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011631"}],"sourceNote":"","synonyms":["Ferroportin Disease","ferroportin disease","hemochromatosis, type 4","hereditary hemochromatosis caused by mutation in SLC40A1","HFE4","SLC40A1 hereditary hemochromatosis"],"takeawayHtml":"","title":"hemochromatosis type 4"},"schemaVersion":1}
